Intestinal immune response is regulated by gut microbe

Tanemoto Shun, Sujino Tomohisa, Takanori Kanai

Research output: Contribution to journalReview article

Abstract

Human Intestine has a diverse population of bacteria which induces pathogens to disrupt not only the intestinal homeostasis but whole body immune systems. Dysbiosis, the abnormal proliferation and reduction of the microbiota, breaks down the homeostasis of the immunity and metabolisms in the host. The evolution of the microbiota analysis technology contributed to reveal the molecular biological complex interaction between the microbiota and its host systemically as well as locally. Because several diseases are caused by the dysbiosis, fecal transplantation would be the new therapeutic target for them. It has been investigated in some intestinal diseases such as CD infection, or inflammatory bowel disease. Here, we review these symbiotic interactions and the current state for the clinical application.

Original languageEnglish
Pages (from-to)408-415
Number of pages8
JournalJapanese Journal of Clinical Immunology
Volume40
Issue number6
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Microbiota
Dysbiosis
Homeostasis
Intestinal Diseases
Inflammatory Bowel Diseases
Intestines
Immune System
Immunity
Technology
Bacteria
Infection
Population
Therapeutics

Keywords

  • Fecal microbiota transplantation
  • Immunity
  • Inflammatory bowel disease
  • Microbiota

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Intestinal immune response is regulated by gut microbe. / Shun, Tanemoto; Tomohisa, Sujino; Kanai, Takanori.

In: Japanese Journal of Clinical Immunology, Vol. 40, No. 6, 01.01.2017, p. 408-415.

Research output: Contribution to journalReview article

Shun, Tanemoto ; Tomohisa, Sujino ; Kanai, Takanori. / Intestinal immune response is regulated by gut microbe. In: Japanese Journal of Clinical Immunology. 2017 ; Vol. 40, No. 6. pp. 408-415.
@article{040035d084344bb7b27e499700b40cfe,
title = "Intestinal immune response is regulated by gut microbe",
abstract = "Human Intestine has a diverse population of bacteria which induces pathogens to disrupt not only the intestinal homeostasis but whole body immune systems. Dysbiosis, the abnormal proliferation and reduction of the microbiota, breaks down the homeostasis of the immunity and metabolisms in the host. The evolution of the microbiota analysis technology contributed to reveal the molecular biological complex interaction between the microbiota and its host systemically as well as locally. Because several diseases are caused by the dysbiosis, fecal transplantation would be the new therapeutic target for them. It has been investigated in some intestinal diseases such as CD infection, or inflammatory bowel disease. Here, we review these symbiotic interactions and the current state for the clinical application.",
keywords = "Fecal microbiota transplantation, Immunity, Inflammatory bowel disease, Microbiota",
author = "Tanemoto Shun and Sujino Tomohisa and Takanori Kanai",
year = "2017",
month = "1",
day = "1",
doi = "10.2177/jsci.40.408",
language = "English",
volume = "40",
pages = "408--415",
journal = "Immunological Medicine",
issn = "0911-4300",
publisher = "Taylor and Francis Ltd.",
number = "6",

}

TY - JOUR

T1 - Intestinal immune response is regulated by gut microbe

AU - Shun, Tanemoto

AU - Tomohisa, Sujino

AU - Kanai, Takanori

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Human Intestine has a diverse population of bacteria which induces pathogens to disrupt not only the intestinal homeostasis but whole body immune systems. Dysbiosis, the abnormal proliferation and reduction of the microbiota, breaks down the homeostasis of the immunity and metabolisms in the host. The evolution of the microbiota analysis technology contributed to reveal the molecular biological complex interaction between the microbiota and its host systemically as well as locally. Because several diseases are caused by the dysbiosis, fecal transplantation would be the new therapeutic target for them. It has been investigated in some intestinal diseases such as CD infection, or inflammatory bowel disease. Here, we review these symbiotic interactions and the current state for the clinical application.

AB - Human Intestine has a diverse population of bacteria which induces pathogens to disrupt not only the intestinal homeostasis but whole body immune systems. Dysbiosis, the abnormal proliferation and reduction of the microbiota, breaks down the homeostasis of the immunity and metabolisms in the host. The evolution of the microbiota analysis technology contributed to reveal the molecular biological complex interaction between the microbiota and its host systemically as well as locally. Because several diseases are caused by the dysbiosis, fecal transplantation would be the new therapeutic target for them. It has been investigated in some intestinal diseases such as CD infection, or inflammatory bowel disease. Here, we review these symbiotic interactions and the current state for the clinical application.

KW - Fecal microbiota transplantation

KW - Immunity

KW - Inflammatory bowel disease

KW - Microbiota

UR - http://www.scopus.com/inward/record.url?scp=85041114945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041114945&partnerID=8YFLogxK

U2 - 10.2177/jsci.40.408

DO - 10.2177/jsci.40.408

M3 - Review article

VL - 40

SP - 408

EP - 415

JO - Immunological Medicine

JF - Immunological Medicine

SN - 0911-4300

IS - 6

ER -